JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Osteopenia

Obligatory

Must not donate if:

The donor is being treated with systemic monoclonal antibody therapy e.g. Denosumab (Prolia)

Discretionary

If the cause is not of itself a reason to defer, even if on treatment to prevent or treat (other than Denosumab), accept.

See if Relevant

Disabled Donor
Malignancy
Steroid Therapy
Vitamins and Other Nutritional Supplements
Autoimmune Disease

 

Additional Information

Osteopenia occurs when there is decreased mineralization (mainly lack of calcium) of bone. It can occur for many reasons so it is important to ensure that it is not associated with a condition that would require a potential donor to be deferred.

Reason for change

The addition of the obligatory deferral for donors with osteoporosis treated with systemic monoclonal antibody therapy and the addition of a link to Autoimmune Disease

Donor Information

If you wish to obtain more information regarding a personal medical issue please contact your National Help Line.

Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.

Update Information

This entry was last updated in:
DSG-WB Edition 203, Release 38.